ASHBURN, Va., March 21, 2023 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announces the dosing of the first patient in its open label clinical trial in Netherton Syndrome patients. The trial is… Read More..

Record Paid Membership Growth Adding 136,000 Since January 1, 2023, a 40% Year-Over-Year Increase   Surpassed 2 Million Paid Members**  Current Cash Position of $10 Million and $27 Million in Short Term Assets  Commenced Previously Announced $2 Million Stock Buyback Extends Record Date to April 7, 2023 for its Planned Special Dividend of a Portion of… Read More..

Senhance Offers the First and Only Digital Laparoscopic Surgery Solution for Pediatric Patients RESEARCH TRIANGLE PARK, N.C., March 20, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of… Read More..